See All Slides - tctmd.com

Slides

Presentation TCT 2013

Multimodality Imaging Requirements in the Screening Evaluation of TAVR Candidates

Presenter: Lutz Buellesfeld

October 31, 2013

Presentation TCT 2013

Guidelines for Commercial TAVR Site Selection in the United States

Presenter: Rhonda Robb

October 31, 2013

Presentation TCT 2013

Getting Started in an Academic Group Practice: What To Do and What Not To Do

Presenter: Ethan Korngold

October 31, 2013

Presentation TCT 2013

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

Presenter: Helene Eltchaninoff

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

Contrarian Position(3)

Presenter: Ajay Kirtane

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Genetic Testing is of Clear Clinical Utility in Selected Patients

Presenter: Jessica Mega

October 31, 2013

Presentation TCT 2013

I'm Sure: Cangrelor Is Required In Addition!

Presenter: Gregg Stone

October 31, 2013

Advertisement

Slides

Multimodality Imaging Requirements in the Screening Evaluation of TAVR Candidates

Guidelines for Commercial TAVR Site Selection in the United States

Getting Started in an Academic Group Practice: What To Do and What Not To Do

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Contrarian Position(3)

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Genetic Testing is of Clear Clinical Utility in Selected Patients

I'm Sure: Cangrelor Is Required In Addition!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content